Standardized predictive receptor immunohistochemical assays: The view forward from our past

American Journal of Clinical Pathology

Volumn 133, Issue 5, 2010, Pages 681-683

  Goldstein, Neal S ^a,b  

^a Advanced Diagnostics Laboratory   (United States)

^b Clarient Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; RECEPTOR; HER2 PROTEIN, HUMAN;

ACCURACY; EDITORIAL; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; PRIORITY JOURNAL; STANDARDIZATION; TISSUE FIXATION; VALIDATION PROCESS; BREAST TUMOR; CHEMISTRY; FEMALE; HUMAN; METHODOLOGY; PATHOLOGY; PREDICTION AND FORECASTING; STANDARD;

BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PATHOLOGY, SURGICAL; PREDICTIVE VALUE OF TESTS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; TISSUE FIXATION;

EID: 77951925553     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPWUWVLJIFSF97     Document Type: Editorial

References (16)

1. Rhodes A, Jasani B, Balaton AJ, et al. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe: documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays. Am J Clin Pathol. 2001;115:44-58.
2. Rhodes A, Jasani B, Balaton AJ, et al. Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. J Clin Pathol. 2000;53:292-301. (Pubitemid 30180402)
3. Allred DC, Carlson RW, Berry DA, et al. NCCN Task Force Report: estrogen receptor and progesterone receptor testing in breast cancer by immunohistochemistry. J Natl Compr Canc Netw. 2009;7(suppl 6):S1-S21.
4. Goldstein NS, Hewitt SM, Taylor CR, et al. Recommendations for improved standardization of immunohistochemistry. Appl Immunohistochem Mol Morphol. 2007;15:124-133.
5. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007;131:18-43.
6. Yaziji H, Taylor CR, Goldstein NS, et al. Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry. Appl Immunohistochem Mol Morphol. 2008;16:513-520.
7. Ibarra JA, Rogers LW, Kyshtoobayeva A, et al. Fixation time does not affect the expression of estrogen receptor. Am J Clin Pathol. 2010;133:747-755.
8. Arber DA. Effect of prolonged formalin fixation on the immunohistochemical reactivity of breast markers. Appl Immunohistochem Mol Morphol. 2002;10:183-186.
9. Diaz LK, Sneige N. Estrogen receptor analysis for breast cancer: current issues and keys to increasing testing accuracy. Adv Anat Pathol. 2005;12:10-19. (Pubitemid 40614485)
10. Goldstein NS, Ferkowicz M, Odish E, et al. Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma. Am J Clin Pathol. 2003;120:86-92. (Pubitemid 37046374)
11. Khoury T, Sait S, Hwang H, et al. Delay to formalin fixation effect on breast biomarkers. Mod Pathol. 2009;22:1457-1467.
12. Neves JI, Begnami MD, Arias V, et al. Antigen retrieval methods and estrogen receptor immunoexpression using 1D5 antibody: a comparative study. Int J Surg Pathol. 2005;13:353-357. (Pubitemid 41688597)
13. Rhodes A, Jasani B, Barnes DM, et al. Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J Clin Pathol. 2000;53:125-130. (Pubitemid 30075056)
14. Umlas J, Tulecke M. The effects of glyoxal fixation on the histological evaluation of breast specimens. Hum Pathol. 2004;35:1058-1062. (Pubitemid 39165336)
15. Vassallo J, Pinto GA, Alvarenga JM, et al. Comparison of immunoexpression of 2 antibodies for estrogen receptors (1D5 and 6F11) in breast carcinomas using different antigen retrieval and detection methods. Appl Immunohistochem Mol Morphol. 2004;12:177-182. (Pubitemid 38796461)
16. Rhodes A. Quality assurance in immunohistochemistry. Am J Surg Pathol. 2003;27:1284-1285.